source
- Eli Lilly lifts guidance by $10 billion as GLP‑1 sales outpace expectationsEli Lilly said its latest financial guidance is $10 billion higher than previously forecast, driven by strong sales of its GLP‑1 medicines. The company’s commercial performance has repeatedly excee…
- Dren Bio raises $350 million to advance rare blood cancer antibodyDren Bio, a California biotech, announced a $350 million financing round to fund late‑stage development and commercial preparation of its lead therapy, a CD94‑targeting monoclonal antibody known as…